Clinical trial
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
NCT04210791 is registered in ClinicalTrials.gov with Nanjing University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
- Lead sponsor
- Nanjing University School of Medicine
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2010
- Completion date
- December 31, 2030
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
al amyloidosis, plasma cell dyscrasia